BIOCEPT, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-12-31: Reporting owner Wilson Margaret Faye; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-12-31: Reporting owner ROYSTON IVOR; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-12-31: Reporting owner Neff Edward A.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-12-31: Reporting owner HUEBNER BRUCE A; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | Wilson Margaret Faye Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $1.38 exercise price | 2016-01-04 | |
| 2015-12-31 | ROYSTON IVOR Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $1.38 exercise price | 2016-01-04 | |
| 2015-12-31 | Neff Edward A. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $1.38 exercise price | 2016-01-04 | |
| 2015-12-31 | HUEBNER BRUCE A Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $1.38 exercise price | 2016-01-04 | |
| 2015-12-31 | Gerhardt Bruce Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $1.38 exercise price | 2016-01-04 | |
| 2015-12-31 | Chandler Marsha Alpert Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $1.38 exercise price | 2016-01-04 | |
| 2015-12-31 | HALE DAVID F Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $1.38 exercise price | 2016-01-04 | |
| 2015-08-31 | Singh Veena Officer (Sr VP & Sr Med Director) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +175,000 175,000 owned after | $2.01 exercise price | 2015-09-02 | |
| 2015-08-31 | Trivedi Raaj Officer (VP Commercial Operations) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +47,000 47,000 owned after | $2.01 exercise price | 2015-09-02 | |
| 2015-08-31 | Nall Michael W. Director, Officer (CEO & President) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $2.01 exercise price | 2015-09-02 | |
| 2015-08-31 | FOLETTA MARK G Officer (Interim CFO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $2.01 exercise price | 2015-09-02 | |
| 2015-08-31 | ARNOLD LYLE J Officer (SR VP of R&D and CSO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +175,000 175,000 owned after | $2.01 exercise price | 2015-09-02 |